<?xml version="1.0" encoding="UTF-8"?>
<p>In 2016, the U.S. Congress reversed a ban on using federal funds for syringe exchange programs, but many of the rural communities battling the opioid crisis are hesitant to implement comprehensive NEP and other harm reduction services, such as opioid agonist therapy [
 <xref rid="pone.0235150.ref023" ref-type="bibr">23</xref>] Hence, persistent barriers of stigma associated with addiction, drug abuse, and HIV status continues to limit access to preventive health and harm reduction services in vulnerable communities, including rural areas. There is also a lack of comprehensive national legislation that specifically addresses the intersection between the opioid, heroin, and HIV risks in the context of the current national opioid crisis [
 <xref rid="pone.0235150.ref023" ref-type="bibr">23</xref>] Collectively, obstacles remain to interrupting the dangerous transition from opioid abuse to heroin injection drug use and its associated HIV transmission risks, with new clusters of HIV cases among PWID also emerging in other US states [
 <xref rid="pone.0235150.ref024" ref-type="bibr">24</xref>,
 <xref rid="pone.0235150.ref025" ref-type="bibr">25</xref>].
</p>
